medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2008, Number 2

<< Back Next >>

Rev Invest Clin 2008; 60 (2)

Diabetes, pregnancy and birth defects.

Arteaga J, Luna L, Mutchinick OM

Language: Spanish
References: 44
Page: 107-114
PDF size: 74.97 Kb.


ABSTRACT

Background. Diabetes mellitus affects 3 to 10% of pregnant women. The reported frequency of congenital malformations (CM) in diabetic mothers is 5.5 to 10%, contributing these defects to approximately 40% of the neonatal mortality in children of diabetic mothers (CDM). Objective. To investigate the frequency and type of congenital malformations in a sample of livebirths of diabetic mothers from the Mexican population. Material and methods. The analyzed information was obtained from the RYVEMCE (Registro y Vigilancia Epidemiológica de Malformaciones Congénitas). We analysed the type and frequency of the different CM diagnosed. These frequencies were compared with the whole amount of those CM included in the database of our registry (20,381). As part of the analysis, other maternal and neonatal variables were also compared between CDM and the control group. Results. A total of 314 CDM (0.77%), 234 malformed and 80 non malformed were identified. The frequencies of cleft palate (CP), limb reduction defect (LRD) and microcephaly (MIC) were significantly higher in CDM than in the rest of malformed newborns of not diabetic mothers of the RYVEMCE (OR: 9.9, 3.8 and 10.0, respectively). A higher frequency of macrosomia was observed in CDM (18.0%) than in controls (6.1%), OR: 3.4, p ‹ 0.001, in the frequency of preterm birth (28.5% than controls 13.0%), OR: 3.02, p ‹ 0.0001 and in caesarean delivery (71.5% than controls 44.4%) OR: 3.15, p ‹ 0.00001. Conclusions. Our results confirm the higher frequency of CM in CDM and in particular a higher risk for CP, LRD and MIC. Pregnancy and delivery complications such as macrosomia and preterm and caesarean delivery were also more frequent in CDM that controls. Certain associations of CM not described previously, were observed in the studied sample. Our results confirm the need of pregnancy planning including a pre-gestational and gestational control of maternal glycaemia, particularly in a population with such a high prevalence of diabetes mellitus as the observed in the Mexican one.


REFERENCES

  1. Dunne FP, Brydon PA, Proffitt M, Smith T, Gee H, Holder RL. Fetal and maternal. Outcomes in Indo-Asian compared to caucasian women with diabetes in pregnancy. QJM 2000; 93(12): 813-8.

  2. Cheung NW, Wasmer G, Al-Ali J. Risk factors for gestational diabetes among Asian women. Diabetes Care 2001; 24(5): 955-6.

  3. Lazalde B, Sánchez-Urbina R, García de Alba JE, Ramírez- Dueñas ML. Gestational diabetes mellitus and congenital malformations. Ginecol Obstet Mex 2001; 69: 399-405.

  4. Nold JL, Georgieff MK. Infants of diabetic mothers. Pediatr Clin North Am 2004; 51(3): 619-37, viii.

  5. Engelgau MM, Herman WH, Smith PJ, German RR, Aubert RE. The epidemiology of diabetes and pregnancy in the U.S., 1988. Diabetes Care 1995; 18(7): 1029-33.

  6. Feig DS, Palda VA. Type 2 diabetes in pregnancy: a growing concern. Lancet 2002; 359 (9318): 1690-2.

  7. Lerman I, Quibrera R, Gómez-Pérez FJ. Epidemiology of diabetes in Mexico. In: Ekoe JM, Zimmet P, Williams R (eds.). The epidemiology of diabetes. Londres: John Wiley & Sons; 2001.

  8. Rodrígues S, Robinson E, Gray-Donald K. Prevalence of gestational diabetes mellitus among James Bay Cree women in northern Quebec. CMAJ 1999; 160(9): 1293-7.

  9. Vangen S, Stoltenberg C, Holan S, Moe N, Magnus P, Harris JR, Stray-Pedersen B. Outcome of pregnancy among immigrant women with diabetes. Diabetes Care 2003; 26(2): 327-32.

  10. Ramírez R, Nazer H. Recién nacido hijo de madre diabética. Chile: Edición del Servicio de Neonatología, Hospital Clínico Universidad de Chile; 2001, p. 192-7.

  11. Gabbe S, Niebyl J, Simpson J, Sensorik M. Infant of diabetic mother. In: Obstetrics-Normal and problem pregnancies. 4th. Ed. Londres: Churchill Livingstone; 2002, p. 1085- 117.

  12. Steel JM, Duncan LJP. The effect of oral contraceptives on insulin requirements in diabetes. Br J Fam Plan 1978; 3: 77.

  13. Fuhrmann K, Reiher H, Semmler K, Fischer F, Glöckner E. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care 1983; 6(3): 219-23.

  14. Simpson JL, Elias S, Martin AO, Palmer MS, Ogata ES, Radvany RA. Diabetes in pregnancy, Northwestern University Series (1977-1981). I. Prospective study of anomalies in offspring of mothers with diabetes mellitus. Am J Obstet Gynecol 1983; 146 (3): 263-70.

  15. Ylinen K, Aula P, Stenman UH, Kesäniemi-Kuokkanen T, Teramo K. Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy. BMJ 1984; 289(6441): 345-6.

  16. Mills JL, Knopp RH, Simpson JP, Jovanovic-Peterson L, Metzger BE, Holmes LB, Aarons JH, Brown Z, et al. Lack of relations of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 1988; 318(11): 671-6.

  17. Greene MF. Prevention and diagnosis of congenital anomalies in diabetic pregnancies. Clin Perinatol 1993; 20(3): 533-47.

  18. Albert TJ, Landon MB, Wheller JJ, Samuels P, Cheng RF, Gabbe S. Prenatal detection of fetal anomalies in pregnancies complicated by insulin-dependent diabetes mellitus. Am J Obstet Gynecol 1996; 174(5): 1424-8.

  19. Nielsen GL, Nørgard B, Puho E, Rothman KJ, Sørensen HT, Czeizel AE. Risk of specific congenital abnormalities in offspring of women with diabetes. Diabet Med 2005; 22(6): 693-6.

  20. Martínez-Frías ML. Epidemiological analysis of outcomes of pregnancy in diabetic mothers: identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet 1994; 51(2): 108-13.

  21. Kucera J. Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 1971; 7(12): 73-82.

  22. Neave C. Congenital malformation in offspring of diabetics. Perspect Pediatr Pathol 1984; 8(3): 213-22.

  23. McCarter RJ, Kessler II, Comstock GW. Is diabetes mellitus a teratogen or a coteratogen? Am J epidemiol 1987; 125(2): 195-205.

  24. Becerra JE, Khoury MJ, Cordero JF, Erickson JD. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population- based case-control study. Pediatrics 1990; 85(1): 1-9.

  25. Bower C, Stanley F, Connell AF, Gent CR, Massey MS. Birth defects in the infants of aboriginal and non-aboriginal mothers with diabetes in Western Australia. Med J Aust 1992; 156(8): 520-4.

  26. Martínez-Frías ML, Bermejo E, Rodríguez-Pinilla E, Prieto L, Frías JL. Epidemiological analysis of outcomes of pregnancy in gestational diabetic mothers. Am J Med Genet 1998; 78(2): 140-5.

  27. Mutchinick O, Lisker R, Babinski V. Programa mexicano de Registro y Vigilancia Epidemiológica de Malformaciones Congénitas Externas. Salud Pública Mex 1988; 30(1): 88-100.

  28. Macintosh CM, Fleming KM, Bailey JA, Doyle P, Modder J, Acolet D, et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 2006; doi:10.1136/bmj.38856.692986.AE.

  29. Kousseff BG. Gestational diabetes mellitus (Class A): a human teratogen? Am J Med Genet 1992; 83(5): 402-8.

  30. Generoso WM, Rutledge JC, Cain KT, Hughes LA, Braden PW. Exposure of female mice to ethylene oxide within hours after mating leads to fetal malformation and death. Mutat Res 1987; 176(2): 269-74.

  31. Polifka JE, Rutledge JC, Kimmel GL, Dellarco V, Generoso WM. Exposure to ethylene oxide during the early zygotic period induces skeletal anomalies in mouse fetuses. Teratology 1996; 53(1): 1-9.

  32. Moley KH. Hyperglycemia and apoptosis: mechanisms for congenital malformations and pregnancy loss in diabetic women. Trends Endocrinol Metab 2001; 12(2): 78-82.

  33. Phelan SA, Ito M, Loeken MR. Neural tube defects in embryos of diabetic mice: role of the Pax-3 gene and apoptosis. Diabetes 1997; 46(7): 1189-97.

  34. Moley KH, Chi MM, Knudson CM, Korsmeyer SJ, Mueckler MM. Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med 1998; 4(12): 1421-4.

  35. Li R, Thorens B, Loeken MR. Expression of the gene encoding the high-Km glucose transporter 2 by the early postimplantation mouse embryo is essential for neural tube defects associated with diabetic embryopathy. Diabetologia 2007; 50(3): 682-9.

  36. Ewart-Toland A, Yankowitz J, Winder A, Imagire R, Cox VA, Aylsworth AS, Golabi M. Oculoauriculovertebral abnormalities in children of diabetic mothers. Am J Med Genet 2000; 90(4): 303-9.

  37. Malinowska-Polubiec A, Czajkowski K, Sotowska A, Sieiñko J. Course of pregnancy and delivery in patients with pregestational diabetes mellitus. Ginekol Pol 2005; 76(4): 264-9.

  38. Jensen DM, Sørensen B, Feilberg-Jørgensen N, Westergaard JG, Beck-Nielsen H. Maternal and perinatal outcomes in 143 Danish women with gestational diabetes mellitus and 143 controls with a similar risk profile. Diabet Med 2000; 17(4): 281-6.

  39. Lepercq J, Coste J, Theau A, Dubois-Laforgue D, Timsit J. Factors associated with preterm delivery in women with type 1 diabetes: a cohort study. Diabetes Care 2004; 27(12): 2824-8.

  40. Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard JG, Moeller M, Beck-Nielsen H. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care 2004; 27(12): 2819.

  41. Hod M, Damm P, Kaaja R, Visser GH, Dunne F, Demidova I, Hansen AS, Mersebach H. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol 2007; [Epub ahead of print].

  42. Yogev Y, Langer O. Spontaneous preterm delivery and gestational diabetes: the impact of glycemic control. Arch Gynecol Obstet 2007; 276(4): 361-5.

  43. Molsted-Pedersen L, Tygstrup I, Perdersen J. Congenital Malformations in newborn infants of diabetic women. Lancet 1964; 1: 1124.

  44. Page NM, Kemp CF, Butlin DJ, Lowry PJ. Placental peptides as markers of gestational disease. Reproduction 2002; 123(4): 487-95.




2020     |     www.medigraphic.com